There is no commercial support for this activity.

About this speaker:

Marlene Freeman, MD is a Professor of Psychiatry at Harvard Medical School.  She is the Associate Director of the Center for Women’s Mental Health at Massachusetts General Hospital and the Abra Prentice Foundation Chair in Women’s Mental Health at MGH.  She is the Medical Director of the Clinical Trials Network and Institute at MGH.  
She completed medical school at Northwestern University Medical School, residency at the Harvard Longwood Psychiatry Residency Program, and a research fellowship in the Biological Psychiatry Program at the University of Cincinnati College of Medicine. 
She is the Editor-in-Chief for The Journal of Clinical Psychiatry. She is on the Board of Directors of the ASCP and is a Fellow of the American College of Neuropsychopharmacology.

Disclosure Statements:

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he /she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt Health System, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Marlene Freeman, MD, reports the following relationships: Investigator Initiated Trials /Research: JayMac, Sage; Advisory boards: Otsuka, Alkermes, Sunovion; Independent Data Safety and Monitoring Committee: Janssen (Johnson& Johnson); Steering Committee for Educational Activities: Medscape; eduational activities: WebMD.  Dr. Freeman is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry [Current Registry Sponsors: Teva (2018- present), Alkermes, Inc. (2016-Present); Otsuka America Pharmaceutical, Inc. (2008-Present); Forest/Actavis (2016-Present), Sunovion Pharmaceuticals, Inc. (2011-Present)].  As an employee of MGH, Dr. Freeman works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies and NIMH., during the past 12 months. She will discuss evidence-based risks and benefits of a survey of medications in this presentation.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months: Todd Peters, MD, Deepak Prabhakar, MD, Briana Riemer, MD, Louis Marino, MD, Ehsan Syed, MD, Faith Dickerson, Ph.D., Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Laura Webb, RN-BC, MSN, Bruce Boxer, PhD, MBA, MA, MSN, RN, NPD-BC, NEA-BC, MCHES, CPHQ, Stacey Garnett, RN, MSN, Heather Billings, RN, and Jennifer Tornabene.